Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.

MIAMI and CHICAGO, April 27, 2026 /PRNewswire/ -- Xcovery Holdings, Inc., (Xcovery) an evidence-based, innovation-driven pharmaceutical company, today announced an agreement with EVERSANA®, a leading provider of commercialization services to the global life sciences industry, to support...

Read More